Detalles de la búsqueda
1.
Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis.
Proc Natl Acad Sci U S A;
118(19)2021 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33941676
2.
Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells.
Am J Pathol;
182(5): 1671-80, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23506849
3.
Tolerogenic dendritic cells generated in vitro using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance.
Front Immunol;
14: 1045183, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37901231
4.
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies.
Mol Cancer Ther;
22(1): 89-101, 2023 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36343381
5.
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies.
J Immunother Cancer;
10(11)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36323431
6.
Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
Int Immunopharmacol;
8(3): 442-52, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18279798
7.
Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α.
Oncotarget;
6(6): 4428-39, 2015 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25669986
8.
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment.
J Immunother Cancer;
3: 53, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26673090
9.
Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models.
Cancer Immunol Res;
3(2): 136-48, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25370534
10.
Natural and induced regulatory T cells.
Ann N Y Acad Sci;
1029: 180-92, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15681757
11.
Intranasal peptide-induced peripheral tolerance: the role of IL-10 in regulatory T cell function within the context of experimental autoimmune encephalomyelitis.
Vet Immunol Immunopathol;
87(3-4): 357-72, 2002 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-12072259
12.
The tumor targeted superantigen ABR-217620 selectively engages TRBV7-9 and exploits TCR-pMHC affinity mimicry in mediating T cell cytotoxicity.
PLoS One;
8(10): e79082, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24194959
13.
Monotherapeutically nonactive CTLA-4 blockade results in greatly enhanced antitumor effects when combined with tumor-targeted superantigens in a B16 melanoma model.
J Immunother;
35(4): 344-53, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22495392
14.
Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.
Int Immunopharmacol;
9(9): 1063-70, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19410661
15.
Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function.
J Immunol;
176(9): 5329-37, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16622000
16.
Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance.
Eur J Immunol;
36(6): 1374-85, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16708405
17.
IL-2 overcomes the unresponsiveness but fails to reverse the regulatory function of antigen-induced T regulatory cells.
J Immunol;
174(1): 310-9, 2005 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15611254
18.
Bcl-3 and NFkappaB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells.
J Biol Chem;
279(9): 8460-8, 2004 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-14668329
19.
Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo.
J Immunol;
170(3): 1240-8, 2003 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12538682
20.
Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.
J Immunol;
170(10): 5008-17, 2003 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12734345